2022年12月14日 · Durable implantable left ventricular assist devices (LVADs) have been shown to improve survival and quality of life for patients with stage D heart failure. Even though …

Caspase-3（CPP32 / apopain）是关键效应器，因为它放大了来自启动器Caspase的信号，使用对Caspase-3有选择性的 DEVD肽序列 对活化的Caspase-3进行检测，可以检测Caspase-3的活性。

2023年8月8日 · Circulatory support with the use of a left ventricular assist device (LVAD) is an emerging field. The landmark REMATCH trial that compared LVADs with optimal medical …

An understanding of the initial evaluation and management of patients with LVADs is now an essential skill for many health care providers. In this State-of-the-Art Review, we discuss …

2018年12月10日 · Mechanical circulatory support (MCS) with ventricular assist device (VAD) is a safe and efficacious treatment strategy for patients with end-stage heart failure (HF) that is …

2019年4月4日 · Left ventricular assist devices (LVADs) are an increasingly used strategy for the management of patients with advanced heart failure with reduced ejection fraction. Although …

A left ventricular assist device (LVAD) is a pump for patients with advanced heart failure. Once implanted, the LVAD is designed to help the left ventricle of your patient’s heart pump blood to …

A left ventricular assist device (LVAD) is a mechanical pump that providers implant in people who have heart failure. The device helps the lower left chamber (left ventricle) of your heart pump …

Over the past two decades, mechanical circulatory support and left ventricular assist devices (LVAD) have altered the heart failure management landscape. Herein we review the …

Durable implantable left ventricular assist devices (LVADs) have been shown to improve survival and quality of life for patients with stage D heart failure. Even though LVADs remain …